共 50 条
- [6] Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis JOURNAL OF CROHNS & COLITIS, 2022, 16 : I483 - I484
- [9] Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis JOURNAL OF CROHNS & COLITIS, 2022, 16 : I483 - I484